Clinical trial
Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)
NCT07671365 is registered in ClinicalTrials.gov with Methodist Healthcare System of San Antonio as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)
- Lead sponsor
- Methodist Healthcare System of San Antonio
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- July 31, 2026
- Completion date
- August 31, 2030
- Enrollment
- 329 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cardiopulmonary bypass, vasoplegia, vasoplegic shock